Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rilonacept for Prevention of Gout Flares During Allopurinol Initiation
NCT00610363Phase 2Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Nov 2007
- Primary completion
- Oct 2008
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of rilonacept in gout, sponsored by Regeneron Pharmaceuticals. Started Nov 2007; status: completed.
02
Drugs
rilonacept
03
Conditions
gout
Beyond the preview
Go deeper on NCT00610363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00610363.